Pharmacotherapy of heart failure with preserved ejection fraction.


Heart failure with preserved ejection fraction (HFpEF) constitutes ~50% of all heart failure diagnoses and is associated with considerable morbidity and mortality. The treatment of HFpEF can be challenging due to a lack of evidence supporting the benefit of various drug therapies. In practice, treatment can be divided into acute and chronic management… (More)
DOI: 10.1002/phar.1556


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics